Discontinued
Strength
.2 mg/mL
Manufacturer
Athenex Pharmaceutical Division, LLC.NDC
70860078101
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
8/20/2025
Active Ingredients
GLYCOPYRROLATEApproval Type
Generic (ANDA)
FDA Application
ANDA210083On Market Since
1/31/2023
Pharmacological Classes
Anticholinergic
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists
Related Drugs
Same classification
OXYBUTYNIN 5 MG/5 ML SYRUP
Generic
54838051080•Lannett Company Inc.
$0.0321
per ML
OXYBUTYNIN 5 MG/5 ML SOLUTION
Generic
62135052047•Chartwell RX LLC
$0.0321
per ML
OXYBUTYNIN 5 MG TABLET
Generic
64380078108•Strides Pharma Inc.
$0.0468
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003800•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003801•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003810•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00832003850•Upsher-Smith Laboratories LLC
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
00904702761•Major Pharmaceuticals
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020101•KVK-Tech Inc.
$0.0484
per EA
OXYBUTYNIN 5 MG TABLET
Generic
10702020110•KVK-Tech Inc.
$0.0484
per EA